The Effects of AT-533 and AT-533 gel on Liver Cytochrome P450 Enzymes in Rats.
Eur J Drug Metab Pharmacokinet
; 47(3): 345-352, 2022 May.
Article
in En
| MEDLINE
| ID: mdl-35137361
ABSTRACT
BACKGROUND AND OBJECTIVES:
AT-533 is a novel heat shock protein 90 inhibitor, which exhibits various biological activities in vitro and in vivo. Cytochrome P450 (CYP) enzymes in the liver are involved in the biotransformation of drugs and considered to be essential indicators of liver toxicity. The aim of this study was to assess the effect of AT-533, either as active pharmaceutical ingredient or in gel form, on liver CYP enzymes.METHODS:
The effect of AT-533 or AT-533 gel on rat liver cytochrome P450 enzymes, including CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4, was analyzed using LC-MS/MS.RESULTS:
AT-533 and AT-533 gel did not significantly increase or reduce the enzymatic activity of CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 at any treatment dose.CONCLUSIONS:
AT-533 and AT-533 gel did not have any effect on CYP activity and may be considered safe for external use in gel form, as an alternative to conventional treatment.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Microsomes, Liver
/
Cytochrome P-450 CYP1A2
Limits:
Animals
Language:
En
Journal:
Eur J Drug Metab Pharmacokinet
Year:
2022
Document type:
Article